Proteome Sciences (LON:PRM) Stock Price Down 1.9% – Here’s What Happened

Proteome Sciences plc (LON:PRM)’s stock price fell 1.9% during trading on Wednesday. The company traded as low as GBX 1.20 and last traded at GBX 1.43. Approximately 139,611 shares traded hands during trading, a decline of 60% from the average session volume of 347,772 shares. The stock had previously closed at GBX 1.46.

Proteome Sciences Trading Down 1.9%

The company has a current ratio of 0.12, a quick ratio of 0.37 and a debt-to-equity ratio of -161.07. The stock has a market cap of £5.00 million, a P/E ratio of -1.98 and a beta of 0.16. The business’s fifty day simple moving average is GBX 1.45 and its 200 day simple moving average is GBX 1.63.

Proteome Sciences (LON:PRM) last announced its earnings results on Wednesday, September 16th. The company reported GBX (0.41) earnings per share (EPS) for the quarter. Proteome Sciences had a positive return on equity of 23.85% and a negative net margin of 61.46%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.